Volume 110, Issue 6, Pages (September 2002)

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Contractile Function During Angiotensin-II Activation:
Advertisements

Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Targeted Inhibition of β-Adrenergic Receptor Kinase-1–Associated.
Volume 56, Issue 5, Pages (November 1999)
Fig. 1. Timeline: Adult (6-month-old) and old (22-month-old) rats were ovariectomized. Half of the animals received immediate E2 replacement.
Volume 68, Issue 4, Pages (October 2005)
Figure 5 Effect of concomitant PDE3 and PDE4 inhibition on SR Ca2+ load and fractional release in ARVMs. (A) Representative traces of Ca2+
Journal of Molecular and Cellular Cardiology
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte Hypertrophy  E. Shen, Xuehong Diao, Xiaoxia.
by Wei Zhang, and Robert W. Colman
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Volume 41, Issue 4, Pages (October 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 22, Issue 4, Pages (April 1999)
P38γ mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation  D.L. Long, R.F. Loeser  Osteoarthritis.
Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression  Kwang Ho Kim, Jung Ho Back, Yucui Zhu, Josh Arbesman,
Volume 124, Issue 5, Pages (May 2003)
Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine- induced cell death  E. Sarró, O. Tornavaca, M. Plana, A. Meseguer, E.
Volume 80, Issue 6, Pages (September 2011)
Volume 3, Issue 1, Pages (July 2002)
Volume 126, Issue 1, Pages (January 2004)
Zara E Khan, Timothy C Wang, Guanglin Cui, Alfred L Chi, Rod Dimaline 
H.T. Lee, M. Kim, M. Jan, R.B. Penn, C.W. Emala  Kidney International 
Volume 16, Issue 10, Pages (September 2016)
Lori Redmond, Amir H. Kashani, Anirvan Ghosh  Neuron 
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 128, Issue 5, Pages (May 2005)
Increased Steady-State Levels of CUGBP1 in Myotonic Dystrophy 1 Are Due to PKC- Mediated Hyperphosphorylation  N. Muge Kuyumcu-Martinez, Guey-Shin Wang,
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 56, Issue 5, Pages (November 1999)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 16, Issue 3, Pages (March 2002)
Volume 7, Issue 5, Pages (May 2001)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Volume 137, Issue 3, Pages (September 2009)
Volume 67, Issue 4, Pages (April 2005)
Histamine Contributes to Tissue Remodeling via Periostin Expression
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 15, Issue 6, Pages (December 2001)
Volume 118, Issue 6, Pages (June 2000)
PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney.
Volume 63, Issue 2, Pages (February 2003)
Volume 130, Issue 3, Pages (March 2006)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 68, Issue 4, Pages (October 2005)
M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: A predominant role of inhibiting apoptosis via A20  Yuan Yue, Xiao.
Sphingosine-1-phosphate–induced smooth muscle cell migration involves the mammalian target of rapamycin  William J. Tanski, MD, Suzanne M. Nicholl, PhD,
Volume 14, Issue 6, Pages (June 2008)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Volume 79, Issue 9, Pages (May 2011)
Volume 88, Issue 4, Pages (February 1997)
Volume 7, Issue 5, Pages (November 1997)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Volume 10, Issue 1, Pages (July 2002)
Volume 7, Issue 1, Pages (January 2008)
Volume 122, Issue 2, Pages (July 2005)
Volume 27, Issue 2, Pages (August 2007)
Growth hormone reduces chloride secretion in human colonic epithelial cells via EGF receptor and extracellular regulated kinase1   Jimmy Y.C Chow, Katie.
Satoru Funamoto, Ruedi Meili, Susan Lee, Lisa Parry, Richard A. Firtel 
Rsk1 mediates a MEK–MAP kinase cell survival signal
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Volume 122, Issue 1, Pages (January 2002)
John M Schmitt, Philip J.S Stork  Molecular Cell 
Volume 119, Issue 5, Pages (November 2000)
Volume 70, Issue 5, Pages (September 2006)
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Volume 6, Issue 4, Pages (October 2007)
Volume 21, Issue 3, Pages (September 1998)
Presentation transcript:

Volume 110, Issue 6, Pages 737-749 (September 2002) Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways  Michael A. Crackower, Gavin Y. Oudit, Ivona Kozieradzki, Renu Sarao, Hui Sun, Takehiko Sasaki, Emilio Hirsch, Akira Suzuki, Tetsuo Shioi, Junko Irie-Sasaki, Rajan Sah, Hai-Ying M. Cheng, Vitalyi O. Rybin, Giuseppe Lembo, Luigi Fratta, Antonio J. Oliveira-dos-Santos, Jeffery L. Benovic, C.Ronald Kahn, Seigo Izumo, Susan F. Steinberg, Matthias P. Wymann, Peter H. Backx, Josef M. Penninger  Cell  Volume 110, Issue 6, Pages 737-749 (September 2002) DOI: 10.1016/S0092-8674(02)00969-8

Figure 1 Cardiac Hypertrophy in PTEN Mutant Hearts (A) Western blot analysis of proteins from different tissues of mckCRE-PTENΔ/+ and mckCRE-PTENΔ/Δ mice. (B) Western blot analysis for p110α, p110β, p110γ, and p85 expression levels in total heart lysates from 2 representative mckCRE-PTENΔ/+ and two mckCRE-PTENΔ/Δ mice. (C) Representative heart sizes of 10-week-old mckCRE-PTENΔ/+ and mckCRE-PTENΔ/Δ littermates. (D) Heart sections from 10 week (upper and middle images) and 1 year (lower images) old mckCRE-PTENΔ/+ and mckCRE-PTENΔ/Δ mice. The middle and lower images show higher magnifications to detect interstitial fibrosis (trichrome). LV = left ventricle; RV = right ventricle. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)

Figure 2 Cardiac Hypertrophy and PI3K Activation (A) Quantitation of heart/body weight ratios from 10-week-old mckCRE-PTENΔ/+ (n = 8) and mckCRE-PTENΔ/Δ (n = 9) and 12 month old mckCRE-PTENΔ/+ (n = 6) and mckCRE-PTENΔ/Δ (n = 6) littermate mice. (B) Increased cell sizes of cardiomyocytes isolated from 10-week-old mckCRE-PTENΔ/Δ mice. Representative images of isolated cardiomyocytes and quantitation of cell sizes are shown. One hundred individual cells from three different mice were analyzed per group. ** p < 0.01 between genetic groups. (C and D) Northern blot analysis and quantitation (mean values ± SEM) of cardiac hypertrophy markers. GAPDH expression levels were used as a loading control. Results from hearts isolated from 3 individual 10-week-old mckCRE-PTENΔ/+ and 3 different, age-matched mckCRE-PTENΔ/Δ littermate mice are shown. (E and F) Increased AKT/PKB, GSK3β, and p70S6K phosphorylation in total heart extracts from 10-week-old mckCRE-PTENΔ/Δ mice. Western blot of the expression of phospho-AKT/PKB, phospho-GSK3β, phospho-p70S6K, phospho-ERK1/2, and their respective loading controls. Densitometric quantitation of phospho-AKT/PKB and phospho-GSK3β levels relative to total cellular AKT/PKB and GSK3β. Mean values ± SEM are representative of 3 independent experiments. ** p < 0.01 between genetic groups. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)

Figure 3 Modulation of Cardiac Contractility in PTEN and p110γ Mutant Hearts (A) Left ventricular mass (LVM; mean values ± SEM) in hearts from 10-week-old mckCRE-PTENΔ/Δ (n = 8), wild-type (n = 7), p110γ−/− (n = 7), and mckCRE-PTENΔ/Δ p110γ −/− (n = 8) mice. ** p < 0.01 between genetic groups. (B) Percent fractional shorting (% FS) and velocity of circumferential fiber shortening (Vcfs) in 10-week-old mckCRE-PTENΔ/Δ, wild-type, p110γ−/−, and mckCRE-PTENΔ/Δ p110γ−/− double-mutant mice. Mean values ± SEM were determined by echocardiography. ** p < 0.01 between groups. (C) M-mode echocardiographic images of contracting hearts in 10-week-old mckCRE-PTENΔ/Δ, wild-type, p110γ−/−, and mckCRE-PTENΔ/Δ p110γ−/− mice. Note that contracting hearts in mckCRE-PTENΔ/Δ p110γ−/− double mutants are similar to that of p110γ−/− mice. (D) Western blot analysis for p110γ expression in control and p110γ deficient isolated cardiomyoctes. Note the smaller non-specific band. (E) Western blotting for phosphorylated-AKT/PKB, total AKT/PKB protein, p85, p110α, and p110β protein expression in total heart extracts. (F) Representative heart sizes and heart/body weight ratios of 10 week old p110γ+/− and p110γ−/− littermates. Similar data, i.e, no change in heart size, were obtained at 6 and 12 months of age. (G) Western blot analysis of AKT/PKB phosphorylation and total AKT/PKB protein levels in hearts from individual p110γ−/−, mckCRE-PTENΔ/Δ and mckCRE-PTENΔ/Δ p110γ−/− double-mutant mice. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)

Figure 4 Heart Sizes and Functions in mckCRE-PTENΔ/Δ DN-p110α Mice (A) Representative heart sizes of 10-week-old wild-type, DN-p110α, and mckCRE-PTENΔ/Δ DN-p110α littermates. (B) Left ventricular mass (LVM; mean values ± SEM) in hearts from 10 week old mckCRE-PTENΔ/Δ (n = 8), wild-type (n = 6), DN-p110α (n = 4), and mckCRE-PTENΔ/Δ DN-p110α double transgenic (n = 4). ** p < 0.01 between genetic groups. (C) Western blot analysis of AKT/PKB phosphorylation and total AKT/PKB protein levels in hearts from wild-type (lane 1), DN-p110α single transgenic (lane 2), and mckCRE-PTENΔ/Δ DN-p110α double-transgenic (lane 3) mice. (D) M-mode echocardiographic images of contracting hearts in 10-week-old wild-type, mckCRE-PTENΔ/Δ, and mckCRE-PTENΔ/Δ DN-p110α double-transgenic mice. (E) Percent fractional shorting (% FS) and velocity of circumferential fiber shortening (Vcfs) in 10-week- old mckCRE-PTENΔ/Δ (n = 8), wild-type (n = 6), DN-p110α (n = 4), and mckCRE-PTENΔ/Δ DN-p110α double-transgenic (n = 4) mice. Values (mean ± SEM) were determined by echocardiography. ** p < 0.01 between groups. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)

Figure 5 Single Cell Contractility and cAMP Production (A and B) Basal contractility of single cardiomyocytes isolated from mckCRE-PTENΔ/Δ, wild-type, p110γ−/−, and mckCRE-PTENΔ/Δ p110γ−/− double-mutant mice. In (A), representative contractions from single cells are shown. In (B), mean percentage shortening (± SEM) of at least 15 different single cells from 3 different hearts per genotype are shown in the presence and absence of the PI3K inhibitor LY294002 [30 μM]. ** p < 0.01 between groups. (C) Basal cAMP levels (mean ± SEM) in purified cardiomyocytes from mckCRE-PTENΔ/Δ, wild-type, and p110γ−/− mice (n = 4 for each genotype). Samples were either left untreated (−) or treated with wortmannin (wort, +). * p < 0.05 between groups. (D) Activation of adenylate cyclase via forskolin [25 μM] increases the levels of cAMP production (mean ± SEM) in mckCRE-PTENΔ/Δ, wild-type, and p110γ−/− cardiomyocytes to a similar extent. (E) Inhibition of cAMP dependent functions via Rp-cAMPS [25 μM] reduces cell shorting (contractility) in single wild-type and p110γ−/− cardiomyocytes. Mean values (± SEM) of percent shortening in the presence of Rp-cAMPS (left image) and percent decrease in contractility using Rp-cAMPS are shown. ** p < 0.01 between groups. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)

Figure 6 PI3Kγ and β-Adrenergic Signaling (A) GRK kinase activities from fractionated heart lysates from individual mckCRE-PTENΔ/+ and mckCRE-PTENΔ/Δ mice were determined using in vitro kinase assays and rhodopsin as substrate. Since GRKs are recruited to membranes, data from cytosolic and membrane fractions are shown. C = control using recombinant GRK2. The lower image shows a Western blot of total GRK2/3 expression levels in the hearts. (B) β-AR densities were determined using ICYP as a ligand as described in Experimental Procedures (n = 7 for wild-type; n = 5 for mckCRE-PTENΔ/Δ; and n = 5 for p110γ−/−). (C) Induction of cAMP production in response to the selective β2-adrenergic receptor agonist zinterol. Note that zinterol has no detectable effect on β2-AR induced cAMP levels in wild-type cardiomyocytes (n = 5) but significantly increases cAMP levels in p110γ−/− cardiomyocytes (n = 5). * p < 0.05 between groups. (D) Induction of cAMP production in response to β1-adrenergic receptor stimulation. Both wild-type (n = 4) and p110γ−/− cardiomyocytes (n = 4) respond equally to isoproterenol. β2-AR were blocked with pretreatment of ICI 118,551. (E) Western blot analysis of phosphorylated phospholamban (P-PLB) and total phospholamban (PLB) in wild-type and p110γ−/− cardiomyocytes in response to different concentrations of the selective β2-AR agonist zinterol. C = control. Note the increased phosphorylation of PLB in unstimulated p110γ−/− cardiomyocytes that mirrors increased basal cAMP levels in these cells. One representative experiment is shown. Cell 2002 110, 737-749DOI: (10.1016/S0092-8674(02)00969-8)